AE Wealth Management LLC Grows Position in Cencora, Inc. $COR

AE Wealth Management LLC boosted its stake in shares of Cencora, Inc. (NYSE:COR) by 12.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 23,320 shares of the company’s stock after acquiring an additional 2,528 shares during the period. AE Wealth Management LLC’s holdings in Cencora were worth $7,289,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the stock. Acadian Asset Management LLC lifted its stake in shares of Cencora by 947.5% during the 2nd quarter. Acadian Asset Management LLC now owns 257,082 shares of the company’s stock worth $77,069,000 after acquiring an additional 232,539 shares during the last quarter. Segment Wealth Management LLC bought a new stake in shares of Cencora during the third quarter worth $4,830,000. Synergy Asset Management LLC purchased a new stake in shares of Cencora during the third quarter valued at $10,093,000. Exchange Traded Concepts LLC boosted its stake in shares of Cencora by 312.7% during the third quarter. Exchange Traded Concepts LLC now owns 10,458 shares of the company’s stock valued at $3,268,000 after purchasing an additional 7,924 shares during the period. Finally, Central Pacific Bank Trust Division grew its holdings in shares of Cencora by 654.6% in the third quarter. Central Pacific Bank Trust Division now owns 4,188 shares of the company’s stock worth $1,309,000 after purchasing an additional 3,633 shares during the last quarter. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Insider Buying and Selling at Cencora

In other news, EVP Elizabeth S. Campbell sold 3,351 shares of the stock in a transaction on Friday, December 19th. The stock was sold at an average price of $342.10, for a total transaction of $1,146,377.10. Following the completion of the sale, the executive vice president owned 23,891 shares in the company, valued at approximately $8,173,111.10. This represents a 12.30% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Robert P. Mauch sold 5,096 shares of the business’s stock in a transaction on Tuesday, January 20th. The stock was sold at an average price of $354.73, for a total value of $1,807,704.08. Following the transaction, the chief executive officer owned 66,726 shares in the company, valued at approximately $23,669,713.98. This trade represents a 7.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 20,316 shares of company stock worth $7,151,265 over the last three months. Corporate insiders own 0.38% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on COR. Jefferies Financial Group raised shares of Cencora from an “underperform” rating to a “buy” rating in a research report on Thursday, January 22nd. Robert W. Baird set a $415.00 price target on shares of Cencora in a research note on Tuesday, January 13th. Weiss Ratings reissued a “hold (c+)” rating on shares of Cencora in a research note on Monday, December 29th. Evercore ISI set a $400.00 price objective on Cencora and gave the stock an “outperform” rating in a report on Thursday, November 6th. Finally, Wall Street Zen lowered Cencora from a “buy” rating to a “hold” rating in a research report on Friday, November 28th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $393.08.

Cencora Trading Up 2.0%

Shares of NYSE:COR opened at $359.14 on Friday. The company has a market capitalization of $69.67 billion, a PE ratio of 45.17, a P/E/G ratio of 1.68 and a beta of 0.66. The company has a current ratio of 0.90, a quick ratio of 0.55 and a debt-to-equity ratio of 4.32. Cencora, Inc. has a 12-month low of $237.71 and a 12-month high of $377.54. The business’s fifty day simple moving average is $347.62 and its 200-day simple moving average is $323.87.

Cencora (NYSE:COR) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $3.84 earnings per share for the quarter, topping analysts’ consensus estimates of $3.79 by $0.05. Cencora had a return on equity of 227.15% and a net margin of 0.48%.The firm had revenue of $83.73 billion during the quarter, compared to analysts’ expectations of $83.36 billion. During the same period in the prior year, the business posted $3.34 EPS. The firm’s quarterly revenue was up 5.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.450-17.75 EPS. As a group, equities research analysts predict that Cencora, Inc. will post 15.37 earnings per share for the current fiscal year.

Cencora Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, December 1st. Investors of record on Friday, November 14th were paid a dividend of $0.60 per share. This is a boost from Cencora’s previous quarterly dividend of $0.55. The ex-dividend date was Friday, November 14th. This represents a $2.40 annualized dividend and a dividend yield of 0.7%. Cencora’s dividend payout ratio (DPR) is presently 30.19%.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.